| Ticker Details |
|
Cogent Biosciences, Inc.
|
| IPO Date: |
March 26, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$6.58B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.39 | 3.59%
|
| Avg Daily Range (30 D): |
$0.72 | 2.01%
|
| Avg Daily Range (90 D): |
$0.73 | 2.04%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.76M |
| Avg Daily Volume (30 D): |
2.46M |
| Avg Daily Volume (90 D): |
1.95M |
| Trade Size |
| Avg Trade Size (Sh.): |
99 |
| Avg Trade Size (Sh.) (30 D): |
78 |
| Avg Trade Size (Sh.) (90 D): |
73 |
| Institutional Trades |
| Total Institutional Trades: |
3,202 |
| Avg Institutional Trade: |
$2.34M |
| Avg Institutional Trade (30 D): |
$3.46M |
| Avg Institutional Trade (90 D): |
$3.63M |
| Avg Institutional Trade Volume: |
.14M |
| Avg Institutional Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.75M |
| Avg Closing Trade (30 D): |
$18.19M |
| Avg Closing Trade (90 D): |
$13.44M |
| Avg Closing Volume: |
222.15K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-.53
|
$-.61
|
$-2.16
|
|
Diluted EPS
|
$-.53
|
$-.61
|
$-2.16
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-97.35M
|
$-102.49M
|
$-328.94M
|
|
Operating Income / Loss
|
$-103.61M
|
$-99.49M
|
$-333.36M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-70.8M
|
$186.8M
|
$214.26M
|
|
PE Ratio
|
|
|
|
|
|
|